基本信息
浏览量:35
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Prof. M Isabel Lucena is full Professor of Pharmacology, Head of the Pharmacology & Paediatrics Department, Faculty of Medicine at the University of Malaga. She is also scientific director of the Malaga Institute of Biomedical Research (IBIMA) and Director of the Unit of Clinical Pharmacology Service. Malaga University Hospital (Spain). She received training in Hoechst Aktiengesellschaft (Frankfurt; 1980), Tufts University (Boston; 1992), Drug Information Association (Paris; 1996) & Pharmacological Research Institute (Milan; 1997). She is member of The Networked Biomedical Centre for Research into Hepatic and Digestive Diseases (CIBERehd), of the IUPHAR Executive Committee (International Union of Basic and Clinical Pharmacology) and Treasurer of the IUPHAR Clinical Pharmacology Division. She is also the member of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) of the European Medicines Agency (EMA) and assessor of the Spanish Committee for Safety of Medicinal Products for Human Use. She has been elected member of the Scientific Committee on Medicinal Products and Medical Devices de la European Commission Health & Consumer Protection Directorate-General, Brussels (2000-2004). Currently, she is coordinating the Spanish Drug Induced Liver Injury Network as well as the Spanish Latin Drug Induced Liver Injury Network (www.spanishdili.uma.es, www.slatindili.uma.es). She contributes in pre- & postgraduate teaching at University of Granada (1982) & Málaga (since 1983). She received grants from the European Association for the Study of the Liver (EASL), the Carlos III Health Institute, the Andalusian Ministry of Health, CIBERehd, the Iberoamerican Postgraduate University Association (AUIP), the University of Málaga, the Spanish Foundation for Funcional Gastrointestinal Disorders (FEAD), the Economics, Innovation and Science Regional Ministry, the International SAEC Consortium LTD y Bioiberica S.A. Also, she is partner of the Innovative Medicines Initiative IMI-2008-T5 SAFE-T Safer and faster Evidence Based Translation of the European Union Grant Agreement number 523 705 for the development of biomarkers in drug-induced liver injury. She serves as reviewer different medical journals: Hepatology, Journal of Hepatology, Clincal Gastroenterology and Hepatology, Drug Safety, American Journal Gastroenterolgy European Journal of Clinical Pharmacology, Pharmacoepidemiology & Drug Safety, Gut, Frontiers of Genetics, Alimentary Pharmacology and Toxicology, Pharmacogenetics and Genomics, BioMed Central, European Gastroenterol Hepatol, Medicina Clinica (Barc)… Since 2014, she is member of the Editorial Board of Hepatology and Frontiers in Pharmacogenetics & Pharmacogenomics. She coauthored several book chapters & more than 200 articles in major pharmacological and medical journals indexed in the Journal Citation of Reports. She presented more than 300 communications in International & National Scientific Meetings, either as oral or poster, having the respective abstracts published. She gave 80 invited talks in International & National Spanish Meetings. She also won several prizes and recognitions from prestigious scientific societies and entities. She contributes to the development of safety biomarkers and personalized medicine. She is actively involved in the design, development and assessment of independent clinical trials at the National Institute of Health and IBIMA-HUM and contributed to the development of national and international Documents of Consensus on Drug-Induced Liver Injury. Has four utilities model.
研究兴趣
论文共 1 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn